Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Population”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05774639
What this trial is testing

Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
Kashiv BioSciences, LLC 600
Large-scale testing (Phase 3)Study completedNCT01206972
What this trial is testing

Dose-confirmatory Bridging Study in Total Knee Replacement

Who this might be right for
Venous Thromboembolism
Bayer 302
Not applicableStudy completedNCT07399457
What this trial is testing

A Nature-based Physical Activity Therapy Group for College Students

Who this might be right for
Depression and Anxiety Symptom
Kansas State University 6
Very early researchUnknownNCT04726553
What this trial is testing

Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Oklahoma Medical Research Foundation 20
Not applicableStudy completedNCT03558828
What this trial is testing

Testing Adaptive Interventions to Improve Physical Activity for Sedentary Women

Who this might be right for
Physical Activity
Rush University Medical Center 301
Testing effectiveness (Phase 2)Study completedNCT00070642
What this trial is testing

CPG 7909 Injection in Melanoma

Who this might be right for
Carcinoma, Melanoma
Pfizer 184
Very early researchStudy completedNCT01264757
What this trial is testing

Steps Toward Adapting Physical Activity Guidelines for the Lower Mississippi Delta Population

Who this might be right for
Physical Inactivity
Pennington Biomedical Research Center 43
Large-scale testing (Phase 3)Study completedNCT06215859
What this trial is testing

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Who this might be right for
Acute PainPost Operative PainPain
Viatris Specialty LLC 579
Large-scale testing (Phase 3)Study completedNCT02307513
What this trial is testing

Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

Who this might be right for
Behçet's Syndrome
Amgen 207
Early research (Phase 1)Study completedNCT02960568
What this trial is testing

Genetic Variability in CYP2D6 in U.S Active Duty Population

Who this might be right for
Pharmacologic Action
Walter Reed Army Institute of Research (WRAIR) 550
Large-scale testing (Phase 3)Study completedNCT02551874
What this trial is testing

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 650
Large-scale testing (Phase 3)Study completedNCT01687296
What this trial is testing

Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

Who this might be right for
Asthma
GlaxoSmithKline 261
Large-scale testing (Phase 3)Ended earlyNCT01433978
What this trial is testing

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01590459
What this trial is testing

24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate

Who this might be right for
Rheumatoid Arthritis
Vertex Pharmaceuticals Incorporated 359
Large-scale testing (Phase 3)Study completedNCT01464190
What this trial is testing

Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

Who this might be right for
Chronic Kidney Disease Requiring Chronic Dialysis
Vifor Pharma 659
Testing effectiveness (Phase 2)Study completedNCT00280917
What this trial is testing

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Can-Fite BioPharma 254
Large-scale testing (Phase 3)Study completedNCT07482046
What this trial is testing

Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population

Who this might be right for
Heat StressAthletic Performance
Taisho Pharmaceutical Indonesia 37
Early research (Phase 1)Study completedNCT01567358
What this trial is testing

Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Nichi-Iko Pharmaceutical Co., Ltd. 14
Testing effectiveness (Phase 2)Study completedNCT00572585
What this trial is testing

Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Study completedNCT00693940
What this trial is testing

Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])

Who this might be right for
Peripheral Vascular DiseasesCardiovascular Diseases
Northwestern University 194
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation